Fresenius Medical Care Reports Second-Quarter GAAP EPS and Revenue
Fresenius Medical Care (NYSE: FMS) reported second-quarter earnings per share of EUR0.81 under GAAP, with total revenue reaching EUR4.86 billion for the period. The results reflect continued performance in its core dialysis services and products business. The company emphasized improved patient outcomes as a key driver for future growth, reinforcing confidence among investors who view Fresenius Medical Care as a high-yield stock with utilities-like characteristics trading at valuation lows. Analysts remain optimistic about the firm's long-term prospects despite macroeconomic headwinds in healthcare markets.
Topics: Earnings Financial Results GAAP EPS